scorecardresearch
Add as a preferred source on Google
Monday, February 2, 2026
TopicTocilizumab

Topic: Tocilizumab

Hetero Labs in Hyderabad seeks nod to make tocilizumab, key drug for Covid treatment in India

There is no clarity yet on the possible arrangement between Swiss pharmaceutical company Roche, the original manufacturer of tocilizumab, and Hetero.

Tocilizumab is nowhere to be found, and no one seems to know of next availability

States like Delhi, Maharashtra, Chandigarh, Kerala and Chhattisgarh have complained of acute shortage of tocilizumab. The drug is used to treat Covid and rheumatoid arthritis.

On Camera

India’s love-hate relationship with foreign capital holds it back. What Budget 2026 hints at

Reviewing Foreign Exchange Management rules is fine, but India needs to stop being so suspicious of foreign money to hit 10 per cent growth.

Andhra Pradesh missing from Budget spotlight, why Chandrababu Naidu’s still happy

Sitharaman in the 2026-27 Budget has shifted focus away from Amaravati and Polavaram. But TDP is confident about leveraging allocations to accelerate Andhra’s 'next phase of growth'.

10X Budget beef-up for Intelligence Bureau capex, after Pahalgam & Red Fort terror attacks

After lapses exposed by terror attacks at Pahalgam and Delhi's Red Fort, Centre has hiked Intelligence Bureau's expenditure for investments in long-term assets from Rs 257 cr to Rs 2,549 cr. 

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.